Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial update on immunogenicity and safety of GSK's Herpes Zoster vaccine in adults with solid tumors receiving chemotherapy; study completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• HZ/su (not available)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Herpes Zoster, Herpes Zoster Vaccine | Phase 3 | Status: COMPLETED | Results posted: 2018-08-17